CancerNetwork Members: Login | Register
CancerNetwork SearchMedica Medline Drugs

Powered by SearchMedica

 
PUBLICATIONS
NEWS
PODCASTS
TOPICS
BLOGS
NURSES
PATIENTS
JOBS
CONFERENCES
CME
SUPPLEMENTS
 

Home » EHR

 

Medical Informatics — The Debate of Art vs. Science Is Over

By Daniel Essin, MA, MD | November 21, 2011

The envelope please... and the winner is ... (drum roll)... Art.

Back in 1976, the year the Apple I was released, computer “user groups” (UGs) were popular. Enthusiasts could meet in friendly surroundings and swap war stories. Common topics included extolling a great new piece of hardware or software. Members would describe some wonderful thing they just discovered that “you” can do with it, "you" meaning them. They would recount their experiences with WidgetX — the greatest thing since sliced bread (or what a disaster!) You should start using it immediately (or avoid it like the plague.) There were UGs of all kinds with names like HUG, BUG, PUG, SCUG, and MUG.

(MORE: With EHR Use, Computer Literacy Misses the Point)

By 1976, about 10 years had elapsed since the first deployments of computer applications in healthcare and more people who had caught the bug, and the UG bug. Being early adopters of practically everything, many of these folks wanted to spread the word and formed medically-related UGs. Thus it was that in 1977 the first annual Symposium on Computer Applications in Medicine (SCAMC) was held in Washington, D.C., not an UG in name but an UG none the less.

Most of the early work on medical computing was done at academic centers by physicians with faculty appointments. A bit was of a theoretical nature but most involved tinkering with hardware and software in attempts to implement applications. Unfortunately, this kind of work is rarely of interest to the main-line medical journals. Nevertheless, academics must publish to get promoted; if they don't, they don't get tenure. If they don't get tenure they either get shown the door or (for the computer geeks) asked to resign their appointment and work in computer operations. The situation is no different in any other medical specialty. There are great practitioners that don't do scientific research or publish. They get the title of “clinical” professor, not the “real” academic positions.

The inability to garner the academic recognition had been frustrating. The response, spearheaded by some of the graybeards in the field, was a strategy that today would be called re-branding. They coined the name Medical Informatics. Evoking an analogy to mathematics, it was undoubtedly intended to imply the scientific study of information in a medical context.

SCAMC merged with several other groups in 1989 to become the American Medical Informatics Association. The annual meetings continue, much as before, and have continued to have little impact on either basic science or the EHR products that are offered for sale. Most institutions, even research institutions, could care less about scientific research into EHR. They are satisfied to get their medical computer systems from vendors and are not dependent on (and often not interested in) having physicians on the payroll acting as what they consider to be glorified computer technicians. If they need “clinical” input, they promote a nurse. Larger institutions may have a physician as chief medical information officer, reporting to the CIO, assigned the task of getting physician “buy-in” to whatever the management has decided to do. An occasional large independent organization has a physician CIO.

The name change from SCAMC to AMIA has not fundamentally altered how medical informatics is perceived. Doctors that practice the computer trade can be very knowledgeable and technically proficient but they have not, for the most part, succeeded in convincing universities that they are scientists, and frankly, most aren't. Scientists get Nobel Prizes, practitioners get board certified. In retrospect, even those that lamented the lack of academic recognition have fostered the view that it is not science. After 20 years of effort, they have convinced the American Board of Medical Specialties to recognize that practicing the medical computer trade is a medical specialty, which it certainly is. Next year the first examination will be administered for board certification in medical informatics. Soon it will be another one of those specialties, like internal medicine and pediatrics, except that medicine has an extensive theoretical foundation with which the applicant is presumably conversant.

So the answer to the question of whether medical informatics is science or art is settled — it's an art. The only tiny, remaining problem is that today's EHRs still lack a sound scientific foundation and there is still a lot of science that needs to be done if we are to get better systems in the future. The practitioners will be busy configuring EHRs, training users, and writing rules for knowledge bases for years to come. Who will do the scientific research and what will we call the discipline in which those researchers (if there are any) are engaged?

Find out more about Daniel Essin and our other Practice Notes bloggers.

 

Join the Conversation

Want to join the conversation? If you're a healthcare professional, we'd like to hear your comments. Just sign in or register today to become part of our growing, online community.

More from Daniel Essin

Qualitative Evaluation Can Help Keep Your Eye on the EHR Ball

EHRs in the Cloud: Hiding Flaws Don't Make Them Disappear

ONCHIT Direct Project a Win for Health IT

The Yin and Yang of Data and the Impact on EHRs

EHRs and Interoperability: Back to the Drawing Board

EHR Construction Doesn't Always Include the Right Tools

The Medical-Industrial Complex

Can Physicians Apply Preventive Medicine Knowledge to EHR?

EHRs: Weighing Form vs. Function

The Ethical Dilemma Created by EHRs

Waste Avoidance: The New Mantra in Healthcare Spending

Reimagining Personal Health Devices

EHR-stored Health Data: Access Issues Confront Cloud Innovation

EHRs a Prime Example of Medicine's 'Software Crisis'

Meaningful Statistics — Can Your EHR Produce Them?

Imagining a Day in Medical Practice with a Possible Future of EHR

EHR Interoperability: I'll Know It When I See It

'Content Neutrality' and Why It Is Important for EHR

The Perils of Over Specification and Underspecification in EHR Systems

IBM's Watson: Has the Time Come for Expert Systems in Medicine?

With Any EHR, Theory is Important but So is Practicality

Doctors Need More Control over the Care Process and EHR is Little Help

With EHRs, Less Patient Data May Be More — Up to a Point

Improve EHR Systems by Rethinking Medical Billing

With EHRs, When Seeking Clarity, Begin at the Beginning

Pondering the Justification for the Federal HIT Push of EHRs

Words Can Be a Window into Fuzzy Thinking about EHRs

One Physician’s New Year's Resolutions

EHRs Only One Victim of Reaction vs. Reason in Healthcare

ICD-10 Shouldn’t Dictate Patient Care or EHR Design

Who Really Benefits from the ICD-10 Transition?

Medical Coding’s Intent is Sometimes Lost in Translation

Medical Informatics — The Debate of Art vs. Science Is Over

Is the EHR Glass Half-Full or Half-Empty?

EHRs and Cars: Don’t Let Perception Cloud Purpose

The Probable Consequences of EHR Certification are Scary

Will an EHR Ever Last as Long as a Patient?

Clinical Quality Measures: Meaningless in Measuring Quality

Interoperability in Healthcare – Easy to Say, Hard to Do

EHRs: Weighing Incentives and What's Best for Patients

With EHRs, Sometimes Less is More

EHR Systems Should Be Taking Larger Strides, But Aren't

Meaningful Use Marches On

To Be or Not To Be an EHR in the Cloud

EHR Cloud Computing Meets Moore's Law

With EHR Use, Computer Literacy Misses the Point





CancerNetwork on Facebook


 
TOPIC INDEX

Cancer Types

 
  • Breast
  • Breast (HER2+)
  • Breast (Triple-Negative)
  • CML
  • Colorectal
  • Gastrointestinal
  • GIST
  • Genitourinary
  • Gynecologic
  • Head & Neck
  • Hematology
  • Kidney (Renal Cell)
  • Leukemia
  • Lung
  • Lymphoma
  • Melanoma
  • Multiple Myeloma
  • Ovarian
  • Prostate
  • Sarcoma

Supportive Care

More Topics

  • Bone Metastases
  • End-of-Life Care
  • Palliative Care
  • Ethics in Oncology
  • Practice Management
  • Practice & Policy


All Topics 


 
   SEARCH MEDICA RX
   Browse drugs by name:
A B C D E F G H I J
K L M N O P Q R S T
U V W X Y Z All      
   Search for drugs:
Search

 

 
FROM PHYSICIANS PRACTICE
Key Differences between FQHCs and RHCs
Chastity Werner, RHIT, June 13, 2013
FQHCs and RHCs take up a unique niche among physician practices. And that affects compensation and billing.
Improving Care Coordination in Your Practice
Susanne Madden,  June 12, 2013
Practices are feverishly working to control the rising costs of healthcare - effective care coordination can help.
Refunding Overpayments: Two Options for Medical Practices
Ericka L. Adler,  June 12, 2013
Medicare and Medicaid providers must return overpayments once identified. Here are two different refund approaches for practices to consider when necessary.
Four Easy Ways to Boost Patient Time of Service Collections
Aubrey Westgate,  June 12, 2013
Simple ways your medical practice staff can increase the likelihood patients will pay when presenting for appointments.
iPad Alternatives for Mobile Physicians
Marisa Torrieri, June 11, 2013
As more physicians are seeing the merits of media tablets, the market is expanding, too.
 

 

 
MOST POPULAR
  • Most Popular
  • Most Emailed
  • Most Recent
  • Papillary Thyroid Carcinoma
  • Robotic-Assisted Radical Prostatectomy: Who Is Benefiting?
  • ASCO: Long-Term Tamoxifen Benefit for Breast Cancer Confirmed
  • A 48-Year-Old Woman With Irregular Vaginal Bleeding
  • Dermatologic Adverse Events Associated With Targeted Therapies
  • Cannabis Linked to Decreased Bladder Cancer Risk
  • Breast Cancer Screening, Risk, and Options for High-Risk Women
  • Rising PSA Level in a 46-Year-Old Man
  • ASCO: Long-Term Tamoxifen Benefit for Breast Cancer Confirmed
  • Recurrent Epithelial Ovarian Cancer: An Update on Treatment
  • Soluble HER2 Levels Prognostic Factor in HER2+ Breast Cancer
  • ASCO: PD-L1 Antibody Elicits Durable Response in RCC
  • RECORD-3: Sunitinib Still Standard First-Line Treatment in Metastatic RCC
  • ASCO: Dabrafenib Shows Activity in BRAF-Mutated NSCLC Patients
  • Preventing Burnout in Oncology
Click here to subscribe to our newsletter
 
COMMENTS
  • Most Commented
  • Most Recent
  • 50 Shades of Pink—And Why It Helps to Know the Difference
  • Preventing Exposure to Hazardous Drugs
  • ASCO: Vinegar Screening Significantly Reduces Cervical Cancer Mortality
  • ASCO: Sulforaphane in Prostate Cancer Found Worthy of Further Investigation
  • Study: Recurrent Heartburn Ups Risk for Throat Cancer
  • Radiation-Induced Enteritis: Incidence, Mechanisms, and Management
  • HER2-Directed Therapy for Metastatic Breast Cancer
  • Accelerated Partial-Breast Irradiation: The Current State of Our Knowledge
  • It’s Time for Clinicians to Reconsider Their Proscription Against the Use of Soyfoods by Breast Cancer Patients
  • 50 Shades of Pink—And Why It Helps to Know the Difference
Click here to subscribe to our newsletter


 
SearchMedica Search Result

Find peer-reviewed literature and websites for practicing medical professionals

CME on EHR
Evidence on EHR
Guidelines on EHR
Patient Education on EHR
Clinical Trials on EHR
Practical Articles on EHR
Research and Reviews on EHR
All "EHR" results


CancerNetwork | ConsultantLive | Diagnostic Imaging | Musculoskeletal Network | OBGYN.net | PediatricsConsultantLive |
Physicians Practice | Psychiatric Times | SearchMedica | Medical Resources

© 1996 - 2013 UBM Medica LLC, a UBM company
Privacy Statement - Terms of Service - Advertising Information - Editorial Policy Statement - UBM Medica Network Privacy Policy